Obesity, obesity-related metabolic conditions, and risk of thyroid cancer in women: results from a prospective cohort study (Sister Study)

被引:10
|
作者
Pasqual, Elisa [1 ]
O'Brien, Katie [2 ]
Rinaldi, Sabina [3 ]
Sandler, Dale P. [2 ]
Kitahara, Cari M. [1 ,4 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA
[2] NIEHS, Epidemiol Branch, Durham, NC USA
[3] Int Agcy Res Canc, 25 Ave Tony Garnier, CS 90627, F-69366 Lyon 07, France
[4] NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr, Rm 7E-456, Bethesda, MD 20892 USA
来源
基金
美国国家卫生研究院;
关键词
Thyroid cancer; Obesity; Obesity associated diseases; Diabetes; Risk factors; Epidemiology; POOLED ANALYSIS; ASSOCIATION; METFORMIN; BREAST;
D O I
10.1016/j.lana.2023.100537
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Thyroid cancer incidence has increased worldwide. Obesity trends may play a role, but the underlying biological pathways are not well-characterized. Therefore, we examined associations of excess adiposity and obesityrelated metabolic conditions with thyroid cancer incidence. Methods From the Sister Study, a cohort of sisters of women with breast cancer, we included 47,739 women who were cancer-free at baseline (2003-2009). Height, weight, waist and hip circumference, and blood pressure were measured at baseline and medical history was self-reported. Cox proportional hazards regression models were adjusted for age (time scale), race/ethnicity, smoking, baseline history of benign thyroid disease, and frequency of routine healthcare visits. Findings During follow-up (median = 12.5; max = 15.9 years), 259 women reported incident thyroid cancer. Body mass index (BMI) (hazard ratio [HR] (per-5 kg/m)2 = 1.25, 95% CI = 1.14-1.37), waist circumference (HRper- 5 cm increase = 1.11, 95% CI = 1.06-1.15), and waist-to-hip ratio (HR (>= 0.85-versus-<0.85) = 1.49, 95% CI = 1.14-1.94) were positively associated with thyroid cancer incidence, as were metabolic syndrome (HR = 1.67, 95% CI = 1.24-2.25), dyslipidemia (HR = 1.46, 95% CI = 1.13-1.90), borderline diabetes (HR = 2.06, 95% CI = 1.15-3.69), hypertension (HR = 1.49, 95% CI = 1.12-1.96), and polycystic ovary syndrome (PCOS, HR = 2.10, 95% CI = 1.20-3.67). These associations were attenuated with additional BMI adjustment, although dyslipidemia (HR = 1.35, 95% CI = 1.04-1.75) and PCOS (HR = 1.86, 95% CI = 1.06-3.28) remained associated with thyroid cancer incidence. Hypothyroidism was not associated with thyroid cancer. Interpretation In this cohort of sisters of women diagnosed with breast cancer, excess adiposity and several obesityrelated metabolic conditions were associated with thyroid cancer incidence. These findings provide insights into potential biological mechanisms linking obesity and thyroid cancer.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Metabolic Obesity Phenotypes and Thyroid Cancer Risk: A Cohort Study
    Kwon, Hyemi
    Chang, Yoosoo
    Cho, Ara
    Ahn, Jiin
    Park, Se Eun
    Park, Cheol-Young
    Lee, Won-Young
    Oh, Ki-Won
    Park, Sung-Woo
    Shin, Hocheol
    Ryu, Seungho
    Rhee, Eun-Jung
    THYROID, 2019, 29 (03) : 349 - 358
  • [2] Sex disparity in the association between metabolic-anthropometric phenotypes and risk of obesity-related cancer: a prospective cohort study
    Gong, Jianxiao
    Liu, Fubin
    Peng, Yu
    Wang, Peng
    Si, Changyu
    Wang, Xixuan
    Zhou, Huijun
    Gu, Jiale
    Qin, Ailing
    Song, Fangfang
    BMC MEDICINE, 2024, 22 (01):
  • [3] Risk of Obesity-Related Cancer After Obesity Surgery in a Population-Based Cohort Study
    Ostlund, Magdalena Plecka
    Lu, Yunxia
    Lagergren, Jesper
    ANNALS OF SURGERY, 2010, 252 (06) : 972 - 976
  • [4] Metabolic obesity phenotypes and the risk of cancer: a prospective study of the Kailuan cohort
    Zheng, Xin
    Wang, Yiming
    Chen, Yue
    Liu, Tong
    Liu, Chenan
    Lin, Shiqi
    Xie, Hailun
    Ma, Xiangming
    Wang, Ziwen
    Shi, Jinyu
    Zhang, Heyang
    Yang, Ming
    Liu, Xiaoyue
    Deng, Li
    Zhang, Qingsong
    Shi, Hanping
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [5] Metabolic Health Reduces Risk of Obesity-Related Cancer in Framingham Study Adults
    Moore, Lynn L.
    Chadid, Susan
    Singer, Martha R.
    Kreger, Bernard E.
    Denis, Gerald V.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (10) : 2057 - 2065
  • [6] Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study
    Xue Tian
    Shuohua Chen
    Penglian Wang
    Qin Xu
    Yijun Zhang
    Yanxia Luo
    Shouling Wu
    Anxin Wang
    Cardiovascular Diabetology, 21
  • [7] Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study
    Tian, Xue
    Chen, Shuohua
    Wang, Penglian
    Xu, Qin
    Zhang, Yijun
    Luo, Yanxia
    Wu, Shouling
    Wang, Anxin
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [8] Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
    Nattenmueller, Cina J.
    Kriegsmann, Mark
    Sookthai, Disorn
    Fortner, Renee Turzanski
    Steffen, Annika
    Walter, Britta
    Johnson, Theron
    Kneisel, Jutta
    Katzke, Verena
    Bergmann, Manuela
    Sinn, Hans Peter
    Schirmacher, Peter
    Herpel, Esther
    Boeing, Heiner
    Kaaks, Rudolf
    Kuehn, Tilman
    BMC CANCER, 2018, 18
  • [9] Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
    Cina J. Nattenmüller
    Mark Kriegsmann
    Disorn Sookthai
    Renée Turzanski Fortner
    Annika Steffen
    Britta Walter
    Theron Johnson
    Jutta Kneisel
    Verena Katzke
    Manuela Bergmann
    Hans Peter Sinn
    Peter Schirmacher
    Esther Herpel
    Heiner Boeing
    Rudolf Kaaks
    Tilman Kühn
    BMC Cancer, 18
  • [10] Metabolic obesity phenotype and risk of obesity-related cancers in the women's health initiative
    Karra, Prasoona
    Winn, Maci
    Anderson, Garnet
    Haaland, Benjamin
    Shadyab, Aladdin H.
    Neuhouser, Marian
    Seguin-Fowler, Rebecca
    Thomson, Cynthia A.
    Coday, Mace
    Wactawski-Wende, Jean
    Stefanick, Marcia L.
    Zhang, Xiaochen
    Cheng, Ting-Yuan David
    Karanth, Shama
    Sun, Yangbo
    Saquib, Nazmus
    Pichado, Margaret
    Jung, Su Yon
    Tabung, Fred
    Summers, Scott A.
    Holland, William L.
    Jalili, Thunder
    Gunter, Marc
    Hardikar, Sheetal
    Playdon, Mary C.
    CANCER RESEARCH, 2023, 83 (07)